A recent study reveals that people who discontinue blockbuster slimming jabs like semaglutide or tirzepatide tend to recover lost weight at a significantly accelerated pace than those who stop traditional diet and exercise regimens.
Published data in a major health publication demonstrates that while obese individuals can lose a large proportion of their total mass while undergoing treatment, the weight is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"Individuals using these drugs need to be cognizant of the potential of fast rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.
This pace of regain suggests a return to original weight in about 18 months.
Weighing Treatments
The analysis, which reviewed 37 of trials involving thousands of patients, compared the results of these new drugs with older methods.
Researchers point out that individuals who shed pounds through dieting typically see a slower weight regain—approximately 0.1 kg a month—post-intervention.
Understanding the Quick Rebound
Doctors believe the way of the jabs is key to understanding the accelerated rebound.
The injections copy a body's own chemical called GLP-1, which moderates appetite.
"Sustained high doses of the hormone concentrations several times higher than normal may cause the body to produce less of its own natural hormone, and could diminish responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making excessive eating much more probable."
An Ongoing Disease?
Health authorities advise the jabs for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications.
Professionals argue that, given the likelihood of relapse, the treatment is often long-term.
This perspective is supported by pharmaceutical companies, who note that the findings "emphasize the chronic character of obesity," similar to managing conditions like hypertension.
Patient Experiences
Individuals who have stopped the medication report a intense return of appetite.
"It was like something that goes on and I was suddenly extremely hungry," described an individual.
This challenge is exacerbated if individuals have not developed lasting lifestyle or habit modifications during therapy.
Significant Use
Survey data indicate that a significant number of people in the UK have used these injections in the last 12 months, with desire continuing to grow.
- Use is higher among women compared to men.
- The middle-aged demographic shows the highest level of interest.
- Many access the drugs through private prescriptions rather than the NHS.
In conclusion, researchers emphasize that while the jabs are powerful tools for shedding pounds, they are not a standalone solution and maintained weight loss relies on integrated lifestyle support.
